These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 16740733)
1. Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor. Zhang T; Barber A; Sentman CL Cancer Res; 2006 Jun; 66(11):5927-33. PubMed ID: 16740733 [TBL] [Abstract][Full Text] [Related]
2. Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer. Barber A; Zhang T; DeMars LR; Conejo-Garcia J; Roby KF; Sentman CL Cancer Res; 2007 May; 67(10):5003-8. PubMed ID: 17510432 [TBL] [Abstract][Full Text] [Related]
3. Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways. Zhang T; Barber A; Sentman CL Cancer Res; 2007 Nov; 67(22):11029-36. PubMed ID: 18006849 [TBL] [Abstract][Full Text] [Related]
6. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634 [TBL] [Abstract][Full Text] [Related]
7. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Diefenbach A; Hsia JK; Hsiung MY; Raulet DH Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935 [TBL] [Abstract][Full Text] [Related]
8. Exosomes and the MICA-NKG2D system in cancer. Clayton A; Tabi Z Blood Cells Mol Dis; 2005; 34(3):206-13. PubMed ID: 15885603 [TBL] [Abstract][Full Text] [Related]
9. NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients. Maccalli C; Nonaka D; Piris A; Pende D; Rivoltini L; Castelli C; Parmiani G Clin Cancer Res; 2007 Dec; 13(24):7459-68. PubMed ID: 18094430 [TBL] [Abstract][Full Text] [Related]
12. Targeting of T cells to CEA-expressing tumor cells by chimeric immune receptors with a highly specific single-chain anti-CEA activity. Arakawa F; Shibaguchi H; Xu Z; Kuroki M Anticancer Res; 2002; 22(6C):4285-9. PubMed ID: 12553071 [TBL] [Abstract][Full Text] [Related]
13. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Sáez-Borderías A; Gumá M; Angulo A; Bellosillo B; Pende D; López-Botet M Eur J Immunol; 2006 Dec; 36(12):3198-206. PubMed ID: 17109473 [TBL] [Abstract][Full Text] [Related]
14. Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Groh V; Smythe K; Dai Z; Spies T Nat Immunol; 2006 Jul; 7(7):755-62. PubMed ID: 16732291 [TBL] [Abstract][Full Text] [Related]
15. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809 [TBL] [Abstract][Full Text] [Related]
17. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564 [TBL] [Abstract][Full Text] [Related]
18. Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma. Wu JY; Ernstoff MS; Hill JM; Cole B; Meehan KR Cytotherapy; 2006; 8(2):141-8. PubMed ID: 16698687 [TBL] [Abstract][Full Text] [Related]
19. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression. Song H; Kim J; Cosman D; Choi I Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603 [TBL] [Abstract][Full Text] [Related]
20. The role of the NKG2D receptor for tumor immunity. Coudert JD; Held W Semin Cancer Biol; 2006 Oct; 16(5):333-43. PubMed ID: 16914326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]